Copperwynd Financial’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,730
| Closed | -$685K | – | 129 |
|
|
2021
Q2 | $685K | Buy |
3,730
+15
| +0.4% | +$2.76K | 0.29% | 54 |
|
|
2021
Q1 | $568K | Sell |
3,715
-127
| -3% | -$19.4K | 0.26% | 63 |
|
|
2020
Q4 | $600K | Sell |
3,842
-253
| -6% | -$39.5K | 0.29% | 54 |
|
|
2020
Q3 | $469K | Sell |
4,095
-80
| -2% | -$9.16K | 0.25% | 66 |
|
|
2020
Q2 | $469K | Sell |
4,175
-391
| -9% | -$43.9K | 0.27% | 59 |
|
|
2020
Q1 | $410K | Buy |
4,566
+825
| +22% | +$74.1K | 0.19% | 51 |
|
|
2019
Q4 | $405K | Sell |
3,741
-454
| -11% | -$49.2K | 0.21% | 92 |
|
|
2019
Q3 | $453K | Buy |
+4,195
| New | +$453K | 0.26% | 88 |
|